HOLBROOK, N.Y., Feb. 14, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc. Symbol (OTC PINK: MDIN) announced today that the rollout of it's products to retail store shelves is now ahead of schedule. In fact, products are currently on about 5-10% of contracted store locations. As expected, Northstar began shipping products by January 1st of 2013, and initial national roll-out, was expected to take about a year, which would make Northstar's products available from coast to coast by January of 2014. This timeframe has now been cut in half and is expected to take place in just a few short months. By as early as June of 2013, Northstar expects 100% of currently contracted store locations to be carrying Snorenz, and possibly Stem-Intense as well.

According to Northstar's contacts at several major retailers, like Target, Rite-aid and Walgreens, the products are in line with several thousand other new products and are slowly being added to store shelves, with sales already underway. Additionally, Northstar is working on removing the non-disclosure agreements in place with its largest retail clients, allowing them to publicly state contract details to shareholders.

Northstar's CEO, Nick Chieco commented, "Full roll out of our products at major retail is well underway and we couldn't be happier. The larger chains like Target, Rite-Aid and Walgreens are giving us June-July timeframe for nation-wide fulfillment of new products, which is absolutely amazing. We have also confirmed that we will be added to the websites of several of these large chains as an online direct to consumer sale, which adds a tremendous amount of exposure and distribution potential. For example Walgreens.com alone gets millions of visits per week. Being available on several of these is a game changer"

Additionally, Northstar would like to confirm changes to its company's share structure planned for the 2nd quarter of 2013. The company has already taken steps to decrease the authorized shares from 12,000,000,000 to 999,999,999, and has already decreased the outstanding by over a hundred million shares with more to come.

"These decreases are a big step for our shareholders, and we want to once again confirm no intention of any serious dilution or weakening of our share structure. Tightening up our share structure and decreasing the number of outstanding shares is our goal, and we hope it shows our shareholders that we are sticking to the plan," added Mr. Chieco.

The company concludes that if its products are not on your local store shelves, you can expect that they will be very shortly. In the mean time consumers are encouraged to visit www.Medgeninc.com to purchase Northstar's products, which are also available at www.Amazon.com.

For more information about Northstar please call Jennifer at 877-571-4387 ext. 4 or email investors@northstarbb.com

DISCLAIMER
: This Press Release may contain certain forward-­‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-­‐looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-­‐looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-­‐looking statements.

SOURCE Northstar Global Business Services, Inc.

Copyright 2013 PR Newswire

MedGen (CE) (USOTC:MDIN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos MedGen (CE).
MedGen (CE) (USOTC:MDIN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos MedGen (CE).